Cardiac GR and MR: From development to pathology

Trends in Endocrinology and Metabolism

Volumn 27, Issue 1, 2016, Pages 35-43

  Richardson, Rachel V ^a,b   Batchen, Emma J ^a   Denvir, Martin A ^a   Gray, Gillian A ^a   Chapman, Karen E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

11 HSD; Corticosteroids; Glucocorticoid receptor; Heart; Mineralocorticoid receptor

Indexed keywords

ALDOSTERONE; CORTICOSTEROID; CORTICOSTEROID RECEPTOR; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR;

CARDIOVASCULAR DISEASE; HEART; HEART DISEASE; HEART FAILURE; HEART MUSCLE CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; CARDIAC MUSCLE CELL; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; HEART DISEASES; HUMANS; MYOCYTES, CARDIAC; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; SIGNAL TRANSDUCTION;

EID: 84951834888     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2015.10.001     Document Type: Review

References (67)

1. Fowden A.L., et al. Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance?. Proc. Nutr. Soc. 1998, 57:113-122.
2. Buckingham J.C. Glucocorticoids: exemplars of multi-tasking. Br. J. Pharmacol. 2006, 147:S258-S268.
3. Funder J.W. Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. Annu. Rev. Med. 1997, 48:231-240.
4. Oakley R.H., Cidlowski J.A. Glucocorticoid signaling in the heart: a cardiomyocyte perspective. J. Steroid Biochem. Mol. Biol. 2015, 153:27-34.
5. Bhargava A., Pearce D. Mechanisms of mineralocorticoid action: determinants of receptor specificity and actions of regulated gene products. Trends Endocrinol. Metab. 2004, 15:147-153.
6. Datson N.A., et al. Identification of corticosteroid-responsive genes in rat hippocampus using serial analysis of gene expression. Eur. J. Neurosci. 2001, 14:675-689.
7. Latouche C., et al. Molecular signature of mineralocorticoid receptor signaling in cardiomyocytes: from cultured cells to mouse heart. Endocrinology 2010, 151:4467-4476.
8. Chapman K., et al. 11β-Hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol. Rev. 2013, 93:1139-1206.
9. Addison T. On the Constitutional and Local Effects of Disease of the Supra-renal Capsules 1855, Samuel Highley.
10. De Leo M., et al. Cardiovascular disease in Cushing's syndrome: heart versus vasculature. Neuroendocrinology 2010, 92(Suppl. 1):50-54.
11. Zannad F., et al. Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. Eur. Heart J. 2012, 33:2782-2795.
12. Pitt B., et al. Spironolactone for heart failure with preserved ejection fraction. N. Engl. J. Med. 2014, 370:1383-1392.
13. Yoshida M., et al. Mineralocorticoid receptor is overexpressed in cardiomyocytes of patients with congestive heart failure. Congest. Heart Fail. 2005, 11:12-16.
14. Ohtani T., et al. Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: beneficial effects of mineralocorticoid receptor blocker. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R946-R954.
15. Messaoudi S., et al. Aldosterone, mineralocorticoid receptor, and heart failure. Mol. Cell. Endocrinol. 2012, 350:266-272.
16. Young M.J., Rickard A.J. Mineralocorticoid receptors in the heart: lessons from cell-selective transgenic animals. J. Endocrinol. 2015, 224:R1-R13.
17. Fraccarollo D., et al. Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction. Circulation 2011, 123:400-408.
18. Lother A., et al. Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function. Hypertension 2011, 57:746-754.
19. Rickard A.J., et al. Cardiomyocyte mineralocorticoid receptors are essential for deoxycorticosterone/salt-mediated inflammation and cardiac fibrosis. Hypertension 2012, 60:1443-1450.
20. Rickard A.J., et al. Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure. Hypertension 2009, 54:537-543.
21. Usher M.G., et al. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J. Clin. Invest. 2010, 120:3350-3364.
22. Ouvrard-Pascaud A., et al. Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias. Circulation 2005, 111:3025-3033.
23. Tsai C-T., et al. Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation. J. Am. Coll. Cardiol. 2010, 55:758-770.
24. Guder G., et al. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation 2007, 115:1754-1761.
25. Gilstrap L.C., et al. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens. Statement 1994, 12:1-24.
26. Barker D.J. Fetal origins of coronary heart disease. Br. Med. J. 1995, 311:171-174.
27. Seckl J.R., Holmes M.C. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology. Nat. Clin. Pract. Endocrinol. Metab. 2007, 3:479-488.
28. Fowden A.L., Forhead A.J. Glucocorticoids as regulatory signals during intrauterine development. Exp. Physiol. 2015, Published online June 4, 2015. 10.1113/EP085212.
29. Rog-Zielinska E.A., et al. Glucocorticoids and foetal heart maturation; implications for prematurity and foetal programming. J. Mol. Endocrinol. 2014, 52:R125-R135.
30. Yoder B.A., et al. Impaired urinary cortisol excretion and early cardiopulmonary dysfunction in immature baboons. Pediatr. Res. 2002, 51:426-432.
31. Kim M.Y., et al. Effects of glucocorticoid exposure on growth and structural maturation of the heart of the preterm piglet. PLoS ONE 2014, 9:e93407.
32. de Vries W.B., et al. Suppression of physiological cardiomyocyte proliferation in the rat pup after neonatal glucocorticosteroid treatment. Basic Res. Cardiol. 2006, 101:36-42.
33. Oparil S., et al. Myocardial cell hypertrophy or hyperplasia. Hypertension 1984, 6. III-38-III-43.
34. Ahuja P., et al. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol. Rev. 2007, 87:521-544.
35. de Vries W.B., et al. Alterations in adult rat heart after neonatal dexamethasone therapy. Pediatr. Res. 2002, 52:900-906.
36. Sohn H.J., et al. Aldosterone modulates cell proliferation and apoptosis in the neonatal rat heart. J. Korean Med. Sci. 2010, 25:1296-1304.
37. Feng X., et al. Cortisol stimulates proliferation and apoptosis in the late gestation fetal heart: differential effects of mineralocorticoid and glucocorticoid receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 305:343-350.
38. Rog-Zielinska E.A., et al. Glucocorticoid receptor is required for foetal heart maturation. Hum. Mol. Gen. 2013, 22:3269-3282.
39. Benato F., et al. A living biosensor model to dynamically trace glucocorticoid transcriptional activity during development and adult life in zebrafish. Mol. Cell. Endocrinol. 2014, 392:60-72.
40. Wilson K.S., et al. Early-life perturbations in glucocorticoid activity impacts on the structure, function and molecular composition of the adult zebrafish (Danio rerio) heart. Mol. Cell. Endocrinol. 2015, 414:120-131.
41. Rog-Zielinska E.A., et al. Glucocorticoids promote structural and functional maturation of foetal cardiomyocytes: a role for PGC-1alpha. Cell Death Differ. 2014, 22:1106-1116.
42. Breckenridge R.A., et al. Hypoxic regulation of hand1 controls the fetal-neonatal switch in cardiac metabolism. PLoS Biol. 2013, 11:e1001666.
43. Puente B.N., et al. The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response. Cell 2014, 157:565-579.
44. Adler A., et al. Investigation of the use of antioxidants to diminish the adverse effects of postnatal glucocorticoid treatment on mortality and cardiac development. Neonatology 2010, 98:73-83.
45. Birket M.J., et al. PGC-1α and reactive oxygen species regulate human embryonic stem cell-derived cardiomyocyte function. Stem Cell Rep. 2013, 1:560-574.
46. Oakley R.H., et al. Essential role of stress hormone signaling in cardiomyocytes for the prevention of heart disease. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:17035-17040.
47. Richardson R., et al. Pathological cardiac remodeling caused by cardiomyocyte/vascular smooth muscle glucocorticoid receptor deficiency. Cardiovasc. Res. 2014, 103:S66.
48. Sainte-Marie Y., et al. Conditional glucocorticoid receptor expression in the heart induces atrio-ventricular block. FASEB J. 2007, 21:3133-3141.
49. Rougier J-S., et al. Mineralocorticoid receptor is essential for corticosteroid-induced up-regulation of L-type calcium currents in cultured neonatal cardiomyocytes. Pflügers Arch. 2008, 456:407-412.
50. Hafezi-Moghadam A., et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat. Med. 2002, 8:473-479.
51. Kuster D.W., et al. Left ventricular remodeling in swine after myocardial infarction: a transcriptional genomics approach. Basic Res. Cardiol. 2011, 106:1269-1281.
52. Neuser J., et al. Myeloid-specific deletion of the glucocorticoid receptor increases mitochondrial oxidative stress and impairs wound healing after myocardial infarction. Circulation 2014, 130:A17166.
53. Bouligand J., et al. Familial glucocorticoid receptor haploinsufficiency by non-sense mediated mRNA decay, adrenal hyperplasia and apparent mineralocorticoid excess. PLoS ONE 2010, 5:e13563.
54. Otte C., et al. Glucocorticoid receptor gene, low-grade inflammation, and heart failure: the Heart and Soul Study. J. Clin. Endocrinol. Metab. 2010, 95:2885-2891.
55. van den Akker E.L., et al. Glucocorticoid receptor gene and risk of cardiovascular disease. Arch. Intern. Med. 2008, 168:33-39.
56. Geelhoed J.J., et al. Glucocorticoid receptor-9beta polymorphism is associated with systolic blood pressure and heart growth during early childhood. Generation R Study. Early Hum. Dev. 2011, 87:97-102.
57. Iqbal J., et al. Mineralocorticoid receptor antagonists displace cortisol, not aldosterone, from the human heart. Circulation 2012, 126:A14332.
58. Funder J.W. RALES, EPHESUS and redox. J. Steroid Biochem. Mol. Biol. 2005, 93:121-125.
59. Gomez A.M., et al. Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins. Circulation 2009, 119:2179-2187.
60. Harris A., et al. Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour. Psychoneuroendocrinology 2013, 38:648-658.
61. Escoubet B., et al. Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations. Circ. Cardiovasc. Genet. 2013, 6:381-390.
62. Charmandari E., et al. Primary generalized familial and sporadic glucocorticoid resistance (chrousos syndrome) and hypersensitivity. Endocr. Dev. 2013, 24:67-85.
63. White C.I., et al. Cardiovascular phenotyping of mice with targeted 11β-hydroxysteroid dehydrogenase type 1 deletion. Heart 2012, 98:A4.
64. McSweeney S.J., et al. Improved heart function follows enhanced inflammatory cell recruitment and angiogenesis in 11β-HSD1-deficient mice post-MI. Cardiovasc. Res. 2010, 88:159-167.
65. White C.I., et al. Cardiomyocyte and vascular smooth muscle independent 11β-hydroxysteroid dehydrogenase 1 amplifies infarct expansion, hypertrophy and the development of heart failure following myocardial infarction in male mice. Endocrinology 2015, Published online October 14, 2015. 10.1210/en.2015-1630.
66. Small G.R., et al. Preventing local regeneration of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1 enhances angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:12165-12170.
67. Harris H.J., et al. Intracellular regeneration of glucocorticoids by 11β-hydroxysteroid dehydrogenase (11β-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11β-HSD-1 deficient mice. Endocrinology 2001, 142:114-120.